

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neutropenia | D009503 | — | D70 | — | 1 | 2 | — | — | 2 |
| Chemotherapy-induced febrile neutropenia | D064146 | — | — | — | 1 | 2 | — | — | 2 |
| Drug common name | Balugrastim |
| INN | balugrastim |
| Description | Balugrastim is a protein pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Protein |
| Drug class | colony-stimulating factors: granulocyte colony-stimulating factors (G-CSF) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2108572 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | T6K4P3HIU8 (ChemIDplus, GSRS) |
